Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8

Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer

Total article views   HTML views PDF downloads Totals
14,495 Dovepress* 10,453+ 1,838 12,291
PubMed Central* 4,042 733 4,775
Totals 14,495 2,571 17,066
*Since 30 June 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar